Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03128931 · ClinicalTrials.gov registry record · NA
SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation
A NA study, sponsored by Masimo Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03128931 is a NA study that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 45 participants.
The verdict
NCT03128931, a NA study, was terminated before completion, sponsored by Masimo Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of the study is to collect EEG data with the Masimo SedLine device along with vital signs, patient demographics, anesthetic record and surgical procedure during general anesthesia or sedation.
Interventions
- DEVICE Pediatric SedLine forehead EEG sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-12-23 |
| Est. Completion | 2018-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03128931
The ClinicalTrials.gov registry entry for NCT03128931 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pediatric SedLine forehead EEG sensor is the first listed.
NCT03128931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03128931 about?
NCT03128931 is a clinical study titled "SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation". The purpose of the study is to collect EEG data with the Masimo SedLine device along with vital signs, patient demographics, anesthetic record and surgical procedure during general anesthesia or sedation.
What is the current status of trial NCT03128931?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2016-12-23. Estimated completion is 2018-11-29.
What interventions are being tested in trial NCT03128931?
The interventions under investigation include: Pediatric SedLine forehead EEG sensor (DEVICE).
Who is sponsoring clinical trial NCT03128931?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.